Featured Research

from universities, journals, and other organizations

Those With More Difficult To Treat Forms Of Hepatitis C Are Half As Likely To Get Treated, Study Finds

Date:
November 9, 2009
Source:
The Mount Sinai Hospital / Mount Sinai School of Medicine
Summary:
A new study has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.

A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.

The study is published in the November 1 issue of Journal of Health Care for the Poor and Underserved.

"Overall, only about 30 percent of hepatitis C patients choose to initiate treatment for the disease," said Thomas McGinn, MD, senior study author and Chief of General Internal Medicine at Mount Sinai School of Medicine. "It's a huge problem that needs to be addressed. This study confirms that genotype is a major barrier to treatment. We hope these findings will lead to changes in how physicians approach patient care in a way that increases the rate of treatment initiation."

Researchers analyzed all patients referred to Mount Sinai's Primary Care Treatment and Screening Program for Hepatitis C between January 2003 and May 2007. The analysis included all hepatitis C clinic patients who were eligible for treatment and to whom treatment was offered.

Of the 168 treatment-eligible patients, 41 began treatment and 127 chose not to. Patients with genotypes 1 and 4 of the disease, which are less responsive to treatment, were less likely to initiate treatment, as were unmarried patients and patients with multiple diseases, or medical comorbidities. Age, gender, language, race, and other risk factors were not found to be significant in the study. Researchers found that:

  • Only 21 percent of individuals with genotypes 1 and 4 initiated treatment, compared to 42 percent of patients with genotypes 2 or 3.
  • 46 percent of patients who chose treatment were married, as opposed to just 19 percent of the patients who declined treatment.
  • Patients who chose treatment had an average of 2.9 medical comorbidities, while patients who did not treat their hepatitis C had an average of 5.2 medical comorbidities.

"More research is needed to determine why these factors affect treatment initiation," said Dr. McGinn. "Because of existing studies on other diseases, we were not surprised that marital status and comorbidities were contributing factors to low treatment rates. However, this is the first study to associate hepatitis C genotype with lower rates of treatment initiation.

"Duration of treatment may be a factor," said McGinn. "Genotypes 1 and 4 of the disease require longer treatment courses, about 9 to 12 months, versus an average of 6 months for genotypes 2 and 3. It's possible the longer duration discourages patients from choosing treatment.

"Furthermore, patients with genotypes 1 and 4 often need a liver biopsy, which many patients incorrectly think are extremely painful. As a result of this study, Mount Sinai has started a program called 'Biopsy Buddies,' in which a patient who has already undergone a liver biopsy consults with a patient who needs one. We're hopeful that by building more support systems for patients we will increase the likelihood that they will choose to receive treatment."


Story Source:

The above story is based on materials provided by The Mount Sinai Hospital / Mount Sinai School of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

The Mount Sinai Hospital / Mount Sinai School of Medicine. "Those With More Difficult To Treat Forms Of Hepatitis C Are Half As Likely To Get Treated, Study Finds." ScienceDaily. ScienceDaily, 9 November 2009. <www.sciencedaily.com/releases/2009/11/091109174252.htm>.
The Mount Sinai Hospital / Mount Sinai School of Medicine. (2009, November 9). Those With More Difficult To Treat Forms Of Hepatitis C Are Half As Likely To Get Treated, Study Finds. ScienceDaily. Retrieved April 25, 2014 from www.sciencedaily.com/releases/2009/11/091109174252.htm
The Mount Sinai Hospital / Mount Sinai School of Medicine. "Those With More Difficult To Treat Forms Of Hepatitis C Are Half As Likely To Get Treated, Study Finds." ScienceDaily. www.sciencedaily.com/releases/2009/11/091109174252.htm (accessed April 25, 2014).

Share This



More Health & Medicine News

Friday, April 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Fungus Killing Bats, Spreading in US

Deadly Fungus Killing Bats, Spreading in US

AP (Apr. 24, 2014) A disease that has killed more than six million cave-dwelling bats in the United States is on the move and wildlife biologists are worried. White Nose Syndrome, discovered in New York in 2006, has now spread to 25 states. (April 24) Video provided by AP
Powered by NewsLook.com
Companies Ramp Up Wellness to Lower Health Costs

Companies Ramp Up Wellness to Lower Health Costs

AP (Apr. 24, 2014) That little voice telling you to exercise, get in shape and get healthy is probably coming from your boss. More companies are beefing up wellness programs to try and cut down their health care costs. (April 24) Video provided by AP
Powered by NewsLook.com
Blood From World's Oldest Woman Suggests Life Limit

Blood From World's Oldest Woman Suggests Life Limit

Newsy (Apr. 24, 2014) Scientists say for the extremely elderly, their stem cells might reach a state of exhaustion. This could limit one's life span. Video provided by Newsy
Powered by NewsLook.com
FDA Wants To Ban Sales Of E-Cigarettes To Minors

FDA Wants To Ban Sales Of E-Cigarettes To Minors

Newsy (Apr. 24, 2014) The Food and Drug Administration wants to crack down on the use of e-cigarettes, banning the sale of the product to minors. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins